New and Generic Drug Approvals
August 18, 2014
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Basaglar | insulin glargine | Injectable;Injection | Eli Lilly and Co | Tentative Approval |
| Cefazolin Sodium | cefazolin sodium | Injectable;Injection | Acs Dobfar | Chemistry New Strength |
| Dexmedetomidine Hydrochloride | dexmedetomidine hydrochloride | Injectable; Injection | Mylan Institutional | Approval |
| Dexmedetomidine Hydrochloride | dexmedetomidine hydrochloride | Injectable;Injection | Par Sterile Products | Approval |
| Docetaxel | docetaxel | Injectable;Injection | Sandoz | Manufacturing Change or Addition |
| Hydromorphone Hydrochloride | hydromorphone hydrochloride | Injectable;Injection | Hospira Inc | Manufacturing Change or Addition |
| Neurontin | gabapentin | Capsule;Oral | Pfizer Pharms | Labeling Revision |
| Neurontin | gabapentin | Tablet;Oral | Pfizer Pharms | Labeling Revision |
| Neurontin | gabapentin | Solution;Oral | Parke Davis | Labeling Revision |
| Rifampin | rifampin | Injectable;Injection | Emcure Pharms Ltd | Approval |
| Tecfidera | dimethyl fumarate | Capsule, Delayed Release;Oral | Biogen Idec Inc | Manufacturing Change or Addition |
No comments:
Post a Comment